Skip to main content

09-09-2019 | Non-small cell lung cancer | Video | Article

Researcher comment: TMB not prognostic for KEYNOTE-189 participant outcomes

Marina Garassino reports the KEYNOTE-189 tumor mutational burden analysis and what the findings mean for this biomarker (4:03).

Read more about the KEYNOTE-189 trial TMB analysis here

Back to the WCLC 2019 conference hub

Related topics

Image Credits